Cardiol Therapeutics, Inc. (CRDL)
2.29
+0.07
(+3.15%)
USD |
NASDAQ |
Sep 09, 13:07
Cardiol Therapeutics Price to Book Value : 15.67 for Sept. 9, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 15.19 |
| September 04, 2026 | 15.05 |
| September 03, 2026 | 14.78 |
| September 02, 2026 | 14.85 |
| September 01, 2026 | 14.71 |
| August 31, 2026 | 13.51 |
| August 28, 2026 | 13.27 |
| August 27, 2026 | 14.10 |
| August 26, 2026 | 14.64 |
| August 25, 2026 | 13.68 |
| August 24, 2026 | 12.73 |
| August 21, 2026 | 12.73 |
| August 20, 2026 | 12.90 |
| August 19, 2026 | 13.41 |
| August 18, 2026 | 12.97 |
| August 17, 2026 | 12.32 |
| August 14, 2026 | 12.32 |
| August 13, 2026 | 11.70 |
| August 12, 2026 | 10.40 |
| August 11, 2026 | 10.26 |
| August 10, 2026 | 10.06 |
| August 07, 2026 | 9.716 |
| August 06, 2026 | 9.306 |
| August 05, 2026 | 9.169 |
| August 04, 2026 | 9.306 |
| Date | Value |
|---|---|
| August 03, 2026 | 8.963 |
| July 31, 2026 | 8.690 |
| July 30, 2026 | 8.279 |
| July 29, 2026 | 7.869 |
| July 28, 2026 | 8.211 |
| July 27, 2026 | 7.903 |
| July 24, 2026 | 8.074 |
| July 23, 2026 | 8.416 |
| July 22, 2026 | 8.758 |
| July 21, 2026 | 8.484 |
| July 20, 2026 | 8.450 |
| July 17, 2026 | 8.279 |
| July 16, 2026 | 8.416 |
| July 15, 2026 | 7.595 |
| July 14, 2026 | 7.869 |
| July 13, 2026 | 7.253 |
| July 10, 2026 | 6.911 |
| July 09, 2026 | 6.788 |
| July 08, 2026 | 6.842 |
| July 07, 2026 | 6.911 |
| July 06, 2026 | 7.321 |
| July 02, 2026 | 7.184 |
| July 01, 2026 | 7.184 |
| June 30, 2026 | 7.253 |
| June 29, 2026 | 6.644 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| InMed Pharmaceuticals, Inc. | 0.6204 |
| NervGen Pharma Corp. | 19.05 |
| Milestone Pharmaceuticals, Inc. | 7.449 |
| Clearmind Medicine, Inc. | 0.0976 |
| Lexaria Bioscience Corp. | 2.724 |
Price to Book Value Related Metrics
| Price | 2.29 |
| Earnings Yield | -10.81% |
| Market Cap | 265.38M |